Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -CZK 72.7B, followed by BridgeBio Pharma (-CZK 46.4B) and Cytokinetics (-CZK 14.7B). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-CZK 72.7B
- Median
- CZK 19.5B
- Combined market value
- CZK 113.1T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -CZK 72.7B | CZK 11.34T | CZK 6,413.48 | 1.50% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -CZK 46.4B | CZK 337.7B | CZK 1,733.43 | 1.50% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -CZK 14.7B | CZK 158.8B | CZK 1,139.87 | 0.76% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -CZK 4.6B | CZK 112.5B | CZK 1,346.45 | 0.31% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -CZK 4B | CZK 394.5B | CZK 6,014.22 | 0.27% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -CZK 2.7B | CZK 117.1B | CZK 2,774.07 | 0.71% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -CZK 1.6B | CZK 167.5B | CZK 480.76 | 2.37% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | CZK 2B | CZK 156.3B | CZK 2,970.64 | 1.74% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | CZK 2.6B | CZK 107.4B | CZK 1,118.74 | 1.55% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 3.1B | CZK 179.9B | CZK 2,594.72 | 0.06% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | CZK 7B | CZK 133B | CZK 2,036.58 | 0.40% down | 31% up | ||
| 12 | ErascaERAS · Health Care | CZK 7.2B | CZK 103.4B | CZK 294.64 | 4.61% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | CZK 7.4B | CZK 86.7B | CZK 633.53 | 3.03% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 10.4B | CZK 136.6B | CZK 966.20 | 1.07% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | CZK 10.5B | CZK 145.8B | CZK 2,149.21 | 0.34% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | CZK 10.9B | CZK 101B | CZK 606.63 | 1.19% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | CZK 11B | CZK 108.2B | CZK 1,922.06 | 0.63% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | CZK 11.2B | CZK 162.8B | CZK 1,860.01 | 1.88% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | CZK 11.6B | CZK 99.3B | CZK 906.77 | 3.00% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 12.6B | CZK 168.2B | CZK 2,140.09 | 1.19% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 13.4B | CZK 212.7B | CZK 9,157.86 | 2.41% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | CZK 13.7B | CZK 180.9B | CZK 2,772.06 | 0.01% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | CZK 14.2B | CZK 110.7B | CZK 636.06 | 2.71% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | CZK 14.4B | CZK 167.1B | CZK 1,526.90 | 2.01% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | CZK 14.4B | CZK 215.4B | CZK 1,425.17 | 2.20% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | CZK 14.7B | CZK 193B | CZK 241.27 | 1.69% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | CZK 15.9B | CZK 200.9B | CZK 2,115.18 | 1.40% up | 286% up | ||
| 28 | InsmedINSM · Health Care | CZK 16.4B | CZK 585.5B | CZK 2,668.66 | 1.52% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | CZK 17.1B | CZK 143.7B | CZK 3,539.24 | 0.91% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | CZK 17.5B | CZK 456.7B | CZK 3,409.49 | 2.03% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | CZK 19.5B | CZK 189.8B | CZK 6,790.74 | 0.10% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | CZK 22.3B | CZK 69.9B | CZK 360.57 | 0.65% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | CZK 22.6B | CZK 133.3B | CZK 6,665.43 | 2.02% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | CZK 40.5B | CZK 174.4B | CZK 1,037.58 | 2.66% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | CZK 74.1B | CZK 758.5B | CZK 1,866.68 | 0.56% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 89.2B | CZK 277.8B | CZK 333.22 | 1.32% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 96B | CZK 348B | CZK 5,420.71 | 1.27% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | CZK 97B | CZK 1.03T | CZK 8,996.42 | 2.10% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | CZK 100.7B | CZK 625.8B | CZK 863.69 | 0.34% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | CZK 130B | CZK 705.4B | CZK 1,144.09 | 0.98% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | CZK 130B | CZK 129.5B | CZK 190.24 | 0.87% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | CZK 135.4B | CZK 259.2B | CZK 1,338.45 | 2.87% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | CZK 145.6B | CZK 293.6B | CZK 587.50 | 2.21% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | CZK 157.8B | CZK 543.9B | CZK 12,771.04 | 1.68% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 175.9B | CZK 1.1T | CZK 943.29 | 0.47% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | CZK 216B | CZK 876.4B | CZK 1,524.12 | 0.20% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | CZK 327.1B | CZK 528.6B | CZK 461.08 | 1.39% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | CZK 410.8B | CZK 2.72T | CZK 1,332.00 | 2.36% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | CZK 415.1B | CZK 3.02T | CZK 11,895.02 | 0.13% up | 27% up | ||
| 50 | GSKGSK · Health Care | CZK 483.4B | CZK 2.18T | CZK 1,086.72 | 0.75% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | CZK 590.1B | CZK 27.52T | CZK 30,894.75 | 1.85% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | CZK 640.3B | CZK 3.9T | CZK 884.03 | 2.32% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | CZK 695.1B | CZK 2.2T | CZK 21,251.68 | 0.22% down | 36% up | ||
| 54 | NovartisNVS · Health Care | CZK 1.03T | CZK 6.56T | CZK 3,475.87 | 1.77% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | CZK 1.03T | CZK 1.52T | CZK 475.32 | 1.22% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | CZK 1.08T | CZK 6.18T | CZK 3,981.87 | 1.76% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | CZK 1.16T | CZK 4.01T | CZK 2,315.65 | 0.55% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | CZK 1.17T | CZK 7.65T | CZK 3,103.95 | 2.64% down | 51% up | ||
| 59 | SanofiSNY · Health Care | CZK 1.76T | CZK 2.53T | CZK 1,051.59 | 0.50% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | CZK 1.81T | CZK 14.73T | CZK 6,119.40 | 1.26% down | 38% up | ||
| 61 | PfizerPFE · Health Care | CZK 1.92T | CZK 3.57T | CZK 626.55 | 1.03% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2370 CZK).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-CZK 72.7B), BridgeBio Pharma (-CZK 46.4B) and Cytokinetics (-CZK 14.7B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of CZK 113.1T as of 18 Nov 2026, 16:06 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.